At Applied Biology our mission is to bring ideas to life that lead to life-changing therapies.
News
- Andy Goren, MD
- ·
- 22 September 2020
Applied Biology and Corpometria Institute Receive National IRB Approval to Study a Potential Breakthrough Therapy for COVID-19
NEXT GENERATION ANTI-ANDROGEN AS A POTENTIAL TREATMENT FOR COVID-19
- Andy Goren, MD
- ·
- 14 July 2020
Applied Biology and Kintor to Collaborate on the use of Proxalutamide for the Treatment of COVID-19
IN A RACE TO FIND A TREATMENT FOR COVID-19, KINTOR HAS TEAMED WITH APPLIED BIOLOGY TO STUDY ITS LEAD ANTI-ANDROGEN AGAINST COVID-19
- BBC Radio
- ·
- 6 June 2020
BBC Interview: The Possible Link Between Covid-19 and the Androgen Receptor
Listen to the Phil Kennedy interview of Professor Andy Goren and Dr. Carlos Wambier.
- The Bald Truth
- ·
- 9 June 2020
COVID-19 Symptoms Appear to be Worse in Bald Men
Watch the Spencer Kobren Interview of Applied Biology's CMO Andy Goren and Fellow Researchers.
- Dermasphere
- ·
- 6 July 2020
COVID, Androgens, Alopecia, and Sunlight
A Conversation with Carlos Wambier and Andy Goren
- Dermasphere
- ·
- 12 June 2020
Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients
Listen to Luke Johnson and Michelle Tarbox, MD on the Dermasphere Podcast (Episode 29) Discussing Applied Biology and Brown University's Covid-19 Research Article — Starting at 43:44 Timestamp.
- ABC News Australia
- ·
- 24 June 2020
Why are More Bald Men Hospitalized for Coronovirus?
The answer could point to a treament.
- Miami Herald
- ·
- 23 June 2020
Bald Men Might Have a Higher Risk of Mortality from COVID-19, Studies Say
Women's levels of androgen are lower than men's, which could explain why they don’t seem to get it as badly in some cases.
- WebMD
- ·
- 12 June 2020
Androgens are the Gateway for Coronovirus to Enter Cells
Male Baldness May Increase Severe COVID-19 Risk.
- FOX NEWS
- ·
- 12 June 2020
Bald Men May be Harder Hit By Coronovirus
Baldness May be a Perfect Predictor of Severity.
- NY POST
- ·
- 11 June 2020
Coronovirus Hits Bald Men Harder?
Scientists believe that androgens may boost the ability of coronavirus to attack cells.
- Forbes Magazine
- ·
- 6 June 2020
Coronovirus Poses a Higher Risk for Bald Men
COVID-19 research is showing that men, particularly bald men, have a worse trajectory.
- Science Magazine
- ·
- 3 June 2020
Coronovirus Hits Men More Severely, Here's Why...
Studying the link between androgens and the severity of COVID-19.
- Andy Goren, MD
- ·
- 2020
Applied Biology in Collaboration with Brown Researchers Announce the Discovery of a Possible Association Between the Genetic Cause of Hair Loss and Severity of COVID-19 Infection
Joint Research Effort Points to Possible Genetic Variation that Pre-disposes COVID-19 Patients to Develop Severe Symptoms
- John McCoy, PhD
- ·
- 2019
Identification of the Sulfotransferase Iso-Enzyme Primarily Responsible for the Bio-Activation of Topical Minoxidil
J McCoy, A Goren, T Naccarato1, M Kovacevic, M Situm, VL Skudar, T Lotti. J Biol Regul Homeost Agents
- Andy Goren, MD
- ·
- 2019
History of Vitiligo
Kovacevic Maja, Franceschi Nika, Situm Mirna, Goren Andy, Stanimirovic Andrija, Valle Yan, Lotti Torello. Springer
- Andy Goren, MD
- ·
- 2019
Platelet Rich Plasma in Androgenetic Alopecia: A Systematic Review
Lotti T., Goren A., Verner I. d’Alessio P., Franca K. J.Dermatol Ther.
- Andy Goren, MD, John McCoy, PhD
- ·
- 2019
Integrative Dermatology: The Microbiome in Hair Disorders
Goren A, Situm M, Kovacevic M, McCoy J, Lotti T. Wiley
- Andy Goren, MD
- ·
- 15 March 2018
PHASE I STUDY COMPLETE
Topical Drug for the Treatment of FPHL in Non-responders to 5% Topical Minoxidil
- Andy Goren, MD
- ·
- 5 October 2017
WCHR CONGRESS
Minoxidil Dose Response Study in Female Pattern Hair Loss Patients Determined to be Non-Responders to 5% Topical Minoxidil
- Andy Goren, MD
- ·
- 22 August 2017
EADV Congress
Minoxidil Dose Response Study in Female Pattern Hair Loss Patients Determined to be Non-Responders to 5% Topical Minoxidil
- Andy Goren, MD
- ·
- 4 June 2017
NAHRS Congress
α1-AR Agonist Induced Piloerection Protects Against the Development of Traction Alopecia
- John McCoy, PhD
- ·
- 4 May 2015
SID Congress
Novel Diagnostic Test Predicts Mean Change in Hair Counts in Female Androgenetic Alopecia Patients Treated with Topical Minoxidil
Applied Biology is a biotechnology company focusing on hair science. Our development of breakthrough drugs and medical devices for the treatment of hair disorders range from genetic markers to harnessing the power of the microbiome. These landmark developments have allowed us to innovate hair treatments for healthier lives. Our commitment extends beyond product innovation to ethical and sustainable medical practices.